IRWD Class A Ironwood Pharmaceuticals, Inc. - Class A Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 6, 2026
$3.64
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$1.4152w निम्न
$5.7852w उच्च
मार्केट कैप (MRQ)
$601M
P/E (TTM)
4.7
EPS (TTM)
$0.77
राजस्व (TTM)
$389M
आपके बैज
52W रेंज
$1–$6
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$6
P/E
4.7
ROE
-55.3%
शुद्ध लाभ मार्जिन
33.4%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
IRWD स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$3.64
मार्केट कैप (MRQ)
$601M
P/E (TTM)
4.7
EPS (TTM)
$0.77
राजस्व (TTM)
$389M
ROE (TTM)
-55.3%
52W रेंज
$1–$6
IRWD स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
स्टॉक विभाजन
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 2 अप्रैल 2019 | 597-for-500 | फॉरवर्ड |
Ironwood Pharmaceuticals, Inc. - Class A Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to produce new ones as leads for drug discovery or as products for use in industry, and to identify drug targets in fungi for antifungal drug discovery. In 2002 the company hired John Talley to lead their antifungal drug discovery efforts, which at the time were focused on identifying small molecules that could inhibit fungal invasins, along with Mark Currie who had also worked at Searle division of Monsanto with Talley, and then had gone to Sepracor, and also Richard Bailey, who had run Monsanto's nutritional business. Currie directed the efforts that led to the discovery of linaclotide, which was based on an enterotoxin produced by some strains of Escherichia coli that cause traveler's diarrhea.
By 2004 the company had raised $99M and was preparing a Phase I trial for linaclotide. By 2006 Microbia was starting to struggle with the different challenges and expenses of drug development, along with its industrial fermentation business and drug discovery efforts, and made the decision to split in two, with "Microbia Precision Engineering" focused on industrial applications led by Bailey and Microbia focused on drug discovery and development. Tate & Lyle invested $7M in the Microbia spinout and took a board seat in 2006. Microbia changed its name to Ironwood in 2008 and shortened the name of the industrial business to Microbia.
By 2009, Ironwood had raised a total of $281M. In early 2010 Ironwood held its IPO, which priced at $11.25 a share, below the target price of $14. Later that year it sold its interests in Microbia to DSM for an undisclosed sum.
Linaclotide (Linzess in the US and Mexico, and as Constella elsewhere), a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause, was approved in the US and Europe in 2012. Most of the marketing rights were licensed to Allergan and Astellas.
It was developing a drug called IW-9179 or recanaclotide but abandoned it in 2016.
Soclenicant (BNC-210; IW-2143) is an anxiolytic that Ironwood licensed and performed R&D on and then abandoned.
In April 2018, the shares of Ironwood Pharmaceuticals closed up more than 10 percent on the news of biotech activist investor, Alex Denner joining its board.
Despite having a billion dollar drug in Linzess, Ironwood - through a series of confounding decisions by management - has seen its stock price crater from a high of $21.16 on July 17, 2018, to its current price of 77 CENTS at the close of trading on August 1, 2025.
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी100
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$296M2016-12-31 → 2025-12-31
EPS$0.152018-12-31 → 2025-12-31
फ्री कैश फ्लो$127M2016-12-31 → 2025-12-31
शुद्ध मार्जिन33.4%2018-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | IRWD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 4.75Y औसत ≈96.0 | ≈96.0 | · | · | |
| P/S (TTM) | 1.55Y औसत ≈3.4 | ≈3.4 | 3.9 | अल्पमूल्यित | |
| P/B (MRQ) | -3.75Y औसत ≈-0.7 | ≈-0.7 | · | · | |
| Price / FCF (मूल्य / FCF) | 4.75Y औसत ≈7.0 | ≈7.0 | · | · | |
| Price / Cash Flow (मूल्य / नकदी प्रवाह) | 4.75Y औसत ≈7.0 | ≈7.0 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | -3.7 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | IRWD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 60.1%5Y औसत ≈-7.3% | ≈-7.3% | -81.6% | शीर्ष स्तर | |
| EBITDA Margin (EBITDA मार्जिन) | 33.6%5Y औसत ≈-7.0% | ≈-7.0% | -81.6% | शीर्ष स्तर | |
| प्रीटैक्स मार्जिन (TTM) | 53.3%5Y औसत ≈-12.4% | ≈-12.4% | -56.0% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | 33.4%5Y औसत ≈-9.5% | ≈-9.5% | -86.5% | शीर्ष स्तर | |
| ROA (TTM) | 41.4%5Y औसत ≈-8.5% | ≈-8.5% | -53.6% | शीर्ष स्तर | |
| ROE (TTM) | -55.3%5Y औसत ≈-107.8% | ≈-107.8% | -68.2% | शीर्ष स्तर | |
| ROIC | -12.9%5Y औसत ≈82.3% | ≈82.3% | 2.1% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | IRWD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 6.15Y औसत ≈8.4 | ≈8.4 | 11.4 | औसत से नीचे | |
| Quick Ratio (त्वरित अनुपात) | 1.15Y औसत ≈8.2 | ≈8.2 | 4.0 | मजबूत तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | IRWD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | -15.7%5Y औसत ≈-4.6% | ≈-4.6% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | -10.3%5Y औसत ≈-3.8% | ≈-3.8% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | -5.3% | · | · | · | |
| EPS YoY | 1400.0%5Y औसत ≈572.1% | ≈572.1% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 2629.2%5Y औसत ≈986.7% | ≈986.7% | · | · | |
| EPS CAGR 3Y | -46.1% | · | · | · | |
| EPS CAGR 5Y | -25.7% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | -48.4% | · | · | · | |
| Net Income CAGR 5Y (शुद्ध आय CAGR 5Y) | -25.7% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | IRWD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.85Y औसत ≈0.6 | ≈0.6 | 0.2 | शीर्ष स्तर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 4.65Y औसत ≈3.7 | ≈3.7 | · | · | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$3.0M | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-5.1%
अगली रिपोर्ट
नव 09, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 6, 2026 | $0.31 | $0.36 | -14.6% |
| 31 मार्च 2026 | $0.24 | $0.24 | -2.0% | |
| 31 दिसमबर 2025 | $-0.01 | $0.01 | -198.0% | |
| 30 सितमबर 2025 | $0.24 | $0.10 | 135.3% | |
| 30 जून 2025 | $0.14 | $0.04 | 243.1% | |
| 31 मार्च 2025 | $-0.14 | $-0.05 | -194.1% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $296M | $351M | $443M | $411M | $414M | $390M | $428M | $347M | $298M | $274M | $150M | $76M | |
| Cost of Revenue | · | · | · | · | · | $3M | $24M | $33M | $19M | $2M | $12.0K | $5M | |
| R&D Expense | $95M | $111M | $116M | $44M | $70M | $88M | $115M | $101M | $88M | $139M | $109M | $102M | |
| SG&A Expense | $82M | $144M | $158M | $116M | $111M | $140M | $172M | $220M | $231M | $173M | $125M | $118M | |
| Operating Expenses | $198M | $258M | $1.39B | $160M | $181M | $247M | $308M | $497M | $314M | $326M | $252M | $246M | |
| Operating Income | $99M | $93M | $-945M | $250M | $232M | $143M | $120M | $-151M | $-15M | $-52M | $-102M | $-169M | |
| Interest Expense | · | · | $22M | $8M | $31M | $29M | $37M | $38M | $36M | $39M | $31M | $21M | |
| Other Non-op | $193.0K | $640.0K | $-3M | $2M | $-32M | $-34M | $-61M | $-43M | $-40M | $-30M | $-41M | $-20M | |
| Pretax Income | $70M | $65M | $-948M | $252M | $201M | $109M | $59M | $-194M | · | · | · | · | |
| Income Tax | $46M | $64M | $83M | $77M | $-328M | $3M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $24M | $880.0K | $-1.00B | $175M | $528M | $106M | $22M | $-282M | $-117M | $-82M | $-143M | · | |
| EPS (Basic) | $0.15 | $0.01 | $-6.45 | $1.13 | $3.26 | $0.67 | $0.14 | $-1.85 | · | · | · | · | |
| EPS (Diluted) | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 | $0.66 | $0.14 | $-1.85 | · | · | · | · | |
| Shares (Basic) | 161,842,000 | 159,083,000 | 155,435,000 | 154,366,000 | 162,245,000 | 159,427,000 | 156,023,000 | 152,634,000 | · | · | · | · | |
| Shares (Diluted) | 162,983,000 | 160,084,000 | 155,435,000 | 186,312,000 | 164,418,000 | 160,655,000 | 156,023,000 | 152,634,000 | · | · | · | · | |
| EBITDA | $100M | $94M | $-944M | $252M | $234M | $145M | $126M | $-233M | · | $-42M | $-90M | $-157M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $215M | $89M | $92M | $656M | $620M | $363M | $177M | $173M | $126M | $54M | $261M | $74M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $96M | $251M | $178M | $174M | |
| Receivables | $47M | $82M | $129M | $115M | $114M | $122M | $11M | $21M | $3M | $933.0K | $3M | $10.0K | |
| Inventory | · | · | · | · | · | · | $648.0K | · | $735.0K | $1M | · | $5M | |
| Prepaid Expense | $12M | $12M | $12M | $8M | $9M | $9M | $11M | $10M | $7M | $9M | $6M | $9M | |
| Current Assets | $274M | $182M | $233M | $781M | $745M | $496M | $307M | $266M | $312M | $380M | $500M | $288M | |
| PP&E (Net) | $3M | $4M | $6M | $6M | $8M | $9M | $12M | $8M | $17M | $21M | $21M | $30M | |
| PP&E (Gross) | $11M | $13M | $14M | $17M | $17M | $21M | $23M | $33M | $86M | $83M | $78M | $83M | |
| Accum. Depreciation | $8M | $8M | $9M | $11M | $10M | $12M | $10M | $26M | $69M | $62M | $57M | $53M | |
| Goodwill | · | · | · | · | · | · | $785.0K | $785.0K | $785.0K | $785.0K | · | · | |
| Intangibles | $2M | $3M | $4M | · | · | · | · | · | $160M | $166M | · | · | |
| Other Non-current Assets | $5M | $6M | $4M | $847.0K | $1M | $943.0K | $790.0K | $89.0K | $870.0K | $1M | $3M | $3M | |
| Total Assets | $397M | $351M | $471M | $1.10B | $1.13B | $559M | $403M | $332M | $606M | $710M | $619M | $329M | |
| Accounts Payable | $3M | $2M | $8M | $483.0K | $935.0K | $661.0K | $4M | $15M | $16M | $18M | $9M | $10M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $38M | $23M | $23M | |
| Short-term Debt | · | · | · | · | · | · | · | $48M | · | · | $25M | $11M | |
| Current Liabilities | $242M | $39M | $276M | $26M | $162M | $32M | $41M | $120M | $66M | $91M | $76M | $61M | |
| Capital Leases | $10M | $12M | $15M | $17M | $18M | $20M | $22M | $158.0K | · | $82.0K | $306.0K | $3M | |
| Other Non-current Liabilities | $22M | $17M | $28M | $10M | $4M | $2M | $734.0K | $3M | $5M | $8M | $10M | · | |
| Total Liabilities | $659M | · | · | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | $199M | $398M | $396M | $454M | $430M | · | · | · | · | $221M | · | |
| Total Debt | · | · | · | · | · | · | · | $48M | · | · | $25M | $11M | |
| Common Stock | $163.0K | $160.0K | $156.0K | $154.0K | $162.0K | $161.0K | $158.0K | $154.0K | · | · | · | · | |
| Retained Earnings | $-1.67B | $-1.70B | $-1.70B | $-696M | $-938M | $-1.47B | $-1.57B | $-1.59B | $-1.31B | $-1.19B | $-1.11B | $-967M | |
| AOCI | $-1M | $923.0K | $-3M | · | · | · | · | · | $-79.0K | $-7.0K | $-86.0K | $-19.0K | |
| Stockholders' Equity | $-262M | $-301M | $-346M | $652M | $606M | $63M | $-93M | $-196M | $10M | $67M | $95M | $89M | |
| Liabilities + Equity | $397M | $351M | $471M | $1.10B | $1.13B | $559M | $403M | $332M | $606M | $710M | $619M | $329M | |
| Shares Outstanding | 163,058,316 | 160,205,899 | 156,354,238 | 154,026,949 | 162,036,461 | 160,616,675 | 157,535,962 | 154,414,691 | · | · | · | · |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $2M | $2M | $6M | $4M | $6M | $10M | $12M | $12M | |
| Stock-based Comp | $17M | $30M | $32M | $27M | $22M | $31M | $31M | $41M | $31M | $29M | $25M | $26M | |
| Deferred Tax | $41M | $68M | $73M | $66M | $-333M | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $8M | $6M | $981.0K | · | · | |
| Restructuring | $21M | $3M | $17M | · | $1M | $15M | $4M | $15M | · | · | · | $551.0K | |
| Other Non-cash | $44M | $4M | $1.08B | $5M | $43M | $29M | $-48M | $161M | · | · | · | · | |
| Operating Cash Flow | $127M | $104M | $183M | $274M | $262M | $169M | $11M | $-71M | $-101M | $-26M | $-107M | $-156M | |
| CapEx | $34.0K | $142.0K | $273.0K | $136.0K | $265.0K | $2M | $7M | $351.0K | $3M | $4M | $4M | $4M | |
| Investing Cash Flow | $-34.0K | $-142.0K | $-1.03B | $-136.0K | $-265.0K | $-2M | $-11M | $89M | $151M | $-178M | $-9M | $-57M | |
| Debt Issued | · | · | · | · | · | · | · | · | $146M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $190M | |
| Stock Repurchased | · | · | · | $126M | $24M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | $-126M | $-24M | · | · | · | · | · | · | $190M | |
| Financing Cash Flow | $216.0K | $-107M | $277M | $-238M | $-5M | $19M | $-1M | $30M | $20M | $-4M | $303M | $211M | |
| Net Change in Cash | $127M | $-4M | $-566M | $36M | $257M | $186M | $-2M | $48M | $71M | $-208M | $187M | · | |
| Taxes Paid | $4M | $8M | $10M | $5M | $3M | $2M | · | · | · | · | · | · | |
| Free Cash Flow | $127M | $103M | $183M | $274M | $262M | $167M | $4M | $-80M | · | $-30M | $-111M | $-159M | |
| Levered FCF | · | · | $160M | $268M | $180M | $138M | · | · | · | · | · | · |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 33.3% | 26.5% | -213.5% | 61.0% | 56.1% | 36.7% | 28.0% | -68.9% | · | -18.9% | -68.3% | -221.6% | |
| Net Margin | 8.1% | 0.25% | -226.4% | 42.6% | 127.7% | 27.3% | 5.0% | -81.5% | · | · | · | · | |
| Pretax Margin | 23.6% | 18.6% | -214.1% | 61.5% | 48.5% | 28.0% | · | · | · | · | · | · | |
| EBITDA Margin | 33.6% | 26.8% | -213.3% | 61.3% | 56.5% | 37.3% | 29.3% | -67.2% | · | -15.2% | -60.5% | -205.4% | |
| ROA | 6.4% | 0.21% | -127.5% | 15.7% | 62.7% | 22.1% | 5.9% | -60.2% | · | · | · | · | |
| ROE | -8.5% | -0.27% | -654.9% | 29.9% | 94.6% | 309.8% | -17.5% | 143.5% | · | · | · | · | |
| ROIC | -12.9% | -0.42% | 297.1% | 26.6% | 101.0% | 222.6% | · | · | · | · | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 4.7 | 0.8 | 30.6 | 4.6 | 15.4 | 7.5 | 2.2 | · | 4.2 | 6.5 | 4.8 | |
| Quick Ratio | 1.1 | 4.4 | 0.8 | 30.2 | 4.5 | 15.1 | 4.6 | 1.6 | · | 3.4 | 5.8 | 4.1 | |
| Debt / Equity | · | · | · | · | · | · | · | -0.2 | · | · | 0.3 | 0.1 | |
| Interest Coverage | · | · | -43.7 | 32.9 | 7.5 | 4.8 | 3.3 | -6.3 | · | -1.3 | -3.3 | -8.0 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 0.6 | 0.4 | 0.5 | 0.8 | 1.2 | 0.7 | · | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | · | · | · | · | · | · | 34.5 | · | · | 3.5 | · | 1.9 | |
| Receivables Turnover | 4.6 | 3.3 | 3.6 | 3.6 | 3.5 | 5.8 | 26.6 | 28.7 | · | 143.5 | 103.4 | 292.3 |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.61 | $-1.88 | $-2.21 | $4.24 | $3.74 | $0.39 | $-0.59 | · | · | · | · | · | |
| Revenue / Share | $1.82 | $2.20 | $2.85 | $2.20 | $2.52 | $2.42 | · | · | · | · | · | · | |
| Cash Flow / Share | $0.78 | $0.65 | $1.18 | $1.47 | $1.59 | $1.05 | · | · | · | · | · | · | |
| Cash / Share | $1.32 | $0.55 | $0.59 | $4.26 | $3.83 | $2.26 | $1.12 | · | · | · | · | · | |
| EPS (TTM) | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 | $0.66 | $0.14 | $-1.85 | $-2.38 | $-2.38 | $-2.38 | $-2.38 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -15.7% | -20.6% | 7.8% | -0.76% | 6.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.3% | -5.3% | 4.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -5.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1400.0% | · | · | -70.1% | 386.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -46.1% | -85.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -25.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2629.2% | · | · | -66.9% | 397.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -48.4% | -88.1% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -25.7% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $296M | $351M | $443M | $411M | $414M | $390M | $428M | $347M | $298M | $274M | $150M | $76M | |
| Net Income TTM | $24M | $880.0K | $-1.00B | $175M | $528M | $106M | $22M | $-282M | $-117M | $-82M | $-143M | · | |
| Market Cap | $550M | $710M | $1.79B | $1.91B | $1.89B | $1.83B | $2.10B | · | · | · | · | · | |
| P/E | 22.5 | 443.0 | -1.8 | 12.9 | 3.6 | 17.3 | 95.1 | -4.7 | -5.3 | -5.4 | -4.1 | -5.4 | |
| P/S | 1.9 | 2.0 | 4.0 | 4.6 | 4.6 | 4.7 | 4.9 | · | · | · | · | · | |
| P/B | -2.1 | -2.4 | -5.2 | 2.9 | 3.1 | 29.2 | -22.5 | · | · | · | · | · | |
| P / Tangible Book | · | · | · | 2.9 | 3.1 | 29.2 | · | · | · | · | · | · | |
| P / Cash Flow | 4.3 | 6.9 | 9.8 | 7.0 | 7.2 | 10.8 | 195.5 | · | · | · | · | · | |
| P / FCF | 4.3 | 6.9 | 9.8 | 7.0 | 7.2 | 11.0 | 593.0 | · | · | · | · | · | |
| Earnings Yield | 4.5% | 0.23% | -56.4% | 7.8% | 27.5% | 5.8% | 1.1% | -21.3% | -19.0% | -18.6% | -24.5% | -18.6% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $107M | $48M | $122M | $85M | $41M | $91M | $92M | $94M | $75M | $118M | $114M | $107M | $104M | $107M | $109M | |
| R&D Expense | $22M | $22M | $22M | $22M | $23M | $27M | $25M | $30M | $30M | $26M | $36M | $33M | $35M | $13M | $10M | $12M | |
| SG&A Expense | $11M | $12M | $19M | $22M | $17M | $24M | $34M | $36M | $37M | $38M | $39M | $36M | $52M | $31M | $28M | $29M | |
| Operating Expenses | $34M | $34M | $41M | $47M | $40M | $70M | $59M | $66M | $69M | $64M | $80M | $74M | $1.19B | $44M | $39M | $40M | |
| Operating Income | $79M | $73M | $7M | $75M | $45M | $-29M | $31M | $26M | $25M | $11M | $38M | $40M | $-1.08B | $60M | $68M | $68M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $10M | $2M | $2M | · | $2M | |
| Other Non-op | $42.0K | $42.0K | $77.0K | $40.0K | $39.0K | $37.0K | $21M | $-8M | $-6M | $-6M | $-7M | $-8M | $7M | $6M | $4M | $1M | |
| Pretax Income | $74M | $65M | $455.0K | $68M | $38M | $-36M | $24M | $17M | $19M | $5M | $30M | $32M | $-1.08B | $66M | $72M | $70M | |
| Income Tax | $22M | $24M | $3M | $28M | $14M | $1M | $22M | $14M | $20M | $9M | $32M | $18M | $13M | $20M | $23M | $20M | |
| Net Income | $51M | $41M | $-2M | $40M | $24M | $-37M | $2M | $4M | $-860.0K | $-4M | $-1M | $15M | $-1.06B | $46M | $49M | $50M | |
| EPS (Basic) | $0.31 | $0.25 | $-0.01 | $0.25 | $0.15 | $-0.23 | $0.01 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.10 | $-6.84 | $0.30 | $0.31 | $0.33 | |
| EPS (Diluted) | $0.31 | $0.24 | $-0.01 | $0.23 | $0.14 | $-0.23 | $0.01 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.09 | $-6.84 | $0.25 | $0.26 | $0.28 | |
| Shares (Basic) | 164,405,000 | 163,451,000 | · | 162,215,000 | 161,723,000 | 160,974,000 | · | 159,706,000 | 159,014,000 | 157,700,000 | · | 155,886,000 | 155,367,000 | 154,452,000 | · | 153,066,000 | |
| Shares (Diluted) | 167,179,000 | 166,690,000 | · | 177,764,000 | 176,837,000 | 160,974,000 | · | 160,232,000 | 159,014,000 | 157,700,000 | · | 186,891,000 | 155,367,000 | 186,680,000 | · | 184,465,000 | |
| EBITDA | $79M | $73M | · | $75M | $45M | $-29M | · | $26M | $25M | $11M | · | $40M | $-1.08B | $60M | · | $68M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $220M | $215M | $140M | $93M | $108M | $89M | $88M | $106M | $122M | $92M | $110M | $175M | $740M | $656M | $574M | |
| Receivables | $113M | $106M | $47M | $120M | $86M | $40M | $82M | $76M | $58M | $72M | $129M | $125M | $119M | $116M | · | $117M | |
| Prepaid Expense | $7M | $6M | $12M | $13M | $13M | $12M | $12M | $14M | $15M | $15M | $12M | $18M | $22M | $9M | · | $7M | |
| Current Assets | $199M | $332M | $274M | $274M | $192M | $161M | $182M | $179M | $178M | $208M | $233M | $254M | $318M | $866M | · | $699M | |
| PP&E (Net) | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $11M | · | · | · | $13M | · | · | · | $14M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $8M | · | · | · | $8M | · | · | · | $9M | · | · | · | · | · | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | · | · | · | |
| Other Non-current Assets | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $4M | $4M | $820.0K | · | $863.0K | |
| Total Assets | $285M | $435M | $397M | $396M | $343M | $327M | $351M | $390M | $396M | $439M | $471M | $524M | $603M | $1.16B | · | $1.04B | |
| Accounts Payable | $911.0K | $3M | $3M | $2M | $1M | $6M | $2M | $3M | $3M | $6M | $8M | $5M | $4M | $118.0K | · | $795.0K | |
| Current Liabilities | $33M | $236M | $242M | $243M | $233M | $48M | $39M | $49M | $46M | $252M | $276M | $281M | $305M | $24M | · | $27M | |
| Capital Leases | $9M | $9M | $10M | $10M | $11M | $12M | $12M | $13M | $13M | $14M | $15M | $15M | $16M | $16M | · | $17M | |
| Other Non-current Liabilities | $21M | $21M | $22M | $22M | $22M | $17M | $17M | $40M | $35M | $29M | $28M | $31M | $31M | $12M | · | $9M | |
| Total Liabilities | $447M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | $200M | $199M | $199M | · | $199M | $199M | $398M | · | $397M | $397M | $397M | · | $396M | |
| Common Stock | $165.0K | $165.0K | $163.0K | $163.0K | $162.0K | $162.0K | $160.0K | $160.0K | $160.0K | $159.0K | $156.0K | $156.0K | $156.0K | $155.0K | · | $153.0K | |
| Retained Earnings | $-1.58B | $-1.63B | $-1.67B | $-1.67B | $-1.71B | $-1.74B | $-1.70B | $-1.70B | $-1.70B | $-1.70B | $-1.70B | $-1.70B | $-1.71B | $-651M | · | $-745M | |
| AOCI | $-324.0K | $-795.0K | $-1M | $-2M | $-2M | $294.0K | $923.0K | $-2M | $-470.0K | $-922.0K | $-3M | $-752.0K | · | · | · | · | |
| Stockholders' Equity | $-162M | $-217M | $-262M | $-264M | $-308M | $-334M | $-301M | $-311M | $-322M | $-331M | $-346M | $-323M | $-346M | $707M | · | $591M | |
| Liabilities + Equity | $285M | $435M | $397M | $396M | $343M | $327M | $351M | $390M | $396M | $439M | $471M | $524M | $603M | $1.16B | · | $1.04B | |
| Shares Outstanding | 165,239,947 | 164,613,406 | 163,058,316 | 162,678,647 | 162,434,130 | 161,809,432 | 160,205,899 | 160,015,888 | 159,739,001 | 158,957,123 | 156,354,238 | 156,125,676 | 156,027,648 | 155,346,103 | · | 153,319,417 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $8M | $9M | $8M | $9M | $8M | $8M | $7M | $7M | $7M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $16M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $639.0K | $5M | · | · | · | · | |
| Operating Cash Flow | $58M | $5M | $75M | $48M | $-15M | $20M | $15M | $10M | $33M | $45M | $36M | $32M | $35M | $80M | $79M | $69M | |
| CapEx | · | · | $-1.0K | $2.0K | $2.0K | $31.0K | $0 | $16.0K | $58.0K | $68.0K | $211.0K | $49.0K | $0 | $13.0K | $-27.0K | $66.0K | |
| Investing Cash Flow | · | · | $1.0K | $-2.0K | $-2.0K | $-31.0K | $0 | $-16.0K | $-58.0K | $-68.0K | $-4M | $-23M | $-999M | $-13.0K | $27.0K | $-66.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | · | · | $122.0K | $0 | $88.0K | $6.0K | $-15M | $-27M | $-49M | $-16M | $-51M | $-75M | $399M | $4M | $3M | $797.0K | |
| Net Change in Cash | $-141M | $5M | $75M | $48M | $-16M | $20M | $348.0K | $-17M | $-16M | $29M | $-19M | $-65M | $-565M | $84M | $82M | $70M | |
| Free Cash Flow | · | · | · | · | · | $20M | · | · | · | $45M | · | · | · | $80M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $51M | · | · | · | $79M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 70.2% | 68.1% | · | 61.8% | 53.2% | -70.8% | · | 28.0% | 26.5% | 14.7% | · | 35.2% | -1008.7% | 57.8% | · | 63.0% | |
| Net Margin | 45.4% | 38.3% | · | 32.8% | 27.7% | -90.9% | · | 4.0% | -0.91% | -5.6% | · | 13.5% | -989.2% | 43.9% | · | 46.3% | |
| Pretax Margin | 65.2% | 61.2% | · | 55.7% | 44.4% | -88.2% | · | 19.0% | 20.0% | 6.6% | · | 28.1% | -1002.2% | 63.3% | · | 64.3% | |
| EBITDA Margin | 70.2% | 68.1% | · | 61.8% | 53.2% | -70.8% | · | 28.0% | 26.5% | 14.7% | · | 35.2% | -1008.7% | 57.8% | · | 63.0% | |
| ROA | 16.3% | 10.7% | · | 10.2% | 6.4% | -9.8% | · | 0.80% | -0.17% | -0.52% | · | 2.0% | -131.9% | 4.3% | · | 4.8% | |
| ROE | -21.8% | -14.8% | · | -13.9% | -7.5% | 11.2% | · | -1.1% | 0.26% | -2.2% | · | 11.4% | -1279.3% | 7.4% | · | 8.6% | |
| ROIC | -34.1% | -20.9% | · | -16.8% | -9.2% | 9.0% | · | -1.7% | 0.35% | 2.8% | · | -5.4% | 317.2% | 5.9% | · | 8.3% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 1.4 | · | 1.1 | 0.8 | 3.3 | · | 3.6 | 3.9 | 0.8 | · | 0.9 | 1.0 | 36.3 | · | 25.8 | |
| Quick Ratio | 5.8 | 1.4 | · | 1.1 | 0.8 | 3.1 | · | 3.3 | 3.6 | 0.8 | · | 0.8 | 1.0 | 35.9 | · | 25.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.5 | · | 4.1 | -588.7 | 39.4 | · | 44.9 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | · | 0.3 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.1 | 1.5 | · | 1.2 | 1.2 | 0.7 | · | 0.9 | 1.1 | 0.8 | · | 0.9 | 1.0 | 1.0 | · | 1.0 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.98 | $-1.32 | · | $-1.62 | $-1.90 | $-2.06 | · | $-1.95 | $-2.01 | $-2.08 | · | $-2.07 | $-2.22 | $4.55 | · | $3.86 | |
| Revenue / Share | $0.68 | $0.64 | · | $0.69 | $0.48 | $0.26 | · | $0.57 | $0.59 | $0.47 | · | $0.61 | $0.69 | $0.56 | · | $0.59 | |
| Cash Flow / Share | · | $0.03 | · | · | · | $0.12 | · | · | · | $0.29 | · | · | · | $0.43 | · | · | |
| Cash / Share | $0.48 | $1.34 | · | $0.86 | $0.57 | $0.67 | · | $0.55 | $0.66 | $0.76 | · | $0.71 | $1.12 | $4.77 | · | $3.75 | |
| EPS (TTM) | $0.77 | $0.60 | · | $0.15 | $-0.06 | $-0.21 | · | $-0.03 | $0.04 | $-6.79 | · | $-6.24 | $-6.05 | $1.00 | · | $0.93 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $389M | $362M | · | $339M | $309M | $318M | · | $378M | $401M | $414M | · | $432M | $427M | $417M | · | $421M | |
| Net Income TTM | $130M | $102M | · | $29M | $-8M | $-32M | · | $-2M | $9M | $-1.05B | · | $-952M | $-917M | $182M | · | $168M | |
| Market Cap | $696M | $578M | · | $213M | $117M | $238M | · | $659M | $1.04B | $1.38B | · | $1.50B | $1.66B | $1.63B | · | $1.59B | |
| P/E | 5.5 | 5.8 | · | 8.7 | -12.0 | -7.0 | · | -137.3 | 163.0 | -1.3 | · | -1.5 | -1.8 | 10.5 | · | 11.1 | |
| P/S | 1.8 | 1.6 | · | 0.6 | 0.4 | 0.7 | · | 1.7 | 2.6 | 3.3 | · | 3.5 | 3.9 | 3.9 | · | 3.8 | |
| P/B | -4.3 | -2.7 | · | -0.8 | -0.4 | -0.7 | · | -2.1 | -3.2 | -4.2 | · | -4.7 | -4.8 | 2.3 | · | 2.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.3 | · | 2.7 | |
| P / Cash Flow | · | 112.8 | · | · | · | 11.9 | · | · | · | 30.8 | · | · | · | 20.4 | · | · | |
| Earnings Yield | 18.3% | 17.1% | · | 11.5% | -8.3% | -14.3% | · | -0.73% | 0.61% | -78.0% | · | -64.8% | -56.9% | 9.5% | · | 9.0% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $296M | $351M | $443M | $411M | $414M |
| परिचालन मार्जिन % | 33.3% | 26.5% | -213.5% | 61.0% | 56.1% |
| शुद्ध आय | $24M | $880.0K | $-1.00B | $175M | $528M |
| तनुकरणित EPS | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 1.1 | 4.7 | 0.8 | 30.6 | 4.6 |
| त्वरित अनुपात | 1.1 | 4.4 | 0.8 | 30.2 | 4.5 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $127M | $103M | $183M | $274M | $262M |
संस्थागत मालिक (13F) 229 फाइलर्स · $708.7M कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
229
धारित मूल्य
$708.7M
नई स्थितियाँ
25
बाहर निकली पोजीशन
32
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 25 (-35 पिछली तिमाही की तुलना में) | 32 (+7 पिछली तिमाही की तुलना में) | 75 (-11 पिछली तिमाही की तुलना में) | 85 (+30 पिछली तिमाही की तुलना में) | -11.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BlackRock, Inc. | $74889826 | 17788557 | 10.57% | शेयर |
| ARMISTICE CAPITAL, LLC | $58653720 | 13932000 | 8.28% | शेयर |
| VANGUARD GROUP INC | $53779120 | 15958196 | 7.59% | शेयर |
| Sarissa Capital Management LP | $38684153 | 9188635 | 5.46% | शेयर |
| STATE STREET CORP | $37088420 | 8809601 | 5.23% | शेयर |
| BANK OF AMERICA CORP /DE/ | $36558810 | 8683803 | 5.16% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $33651481 | 7993226 | 4.75% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $27821819 | 6608508 | 3.93% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $27221528 | 6465921 | 3.84% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $23211225 | 5513355 | 3.28% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $20345036 | 4831657 | 2.87% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $19181135 | 4556089 | 2.71% | शेयर |
| MARSHALL WACE, LLP | $18061293 | 4290093 | 2.55% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $17117708 | 4065964 | 2.42% | शेयर |
| GOLDMAN SACHS GROUP INC | $13951132 | 3313808 | 1.97% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13902439 | 3302242 | 1.96% | शेयर |
| FEDERATED HERMES, INC. | $13603512 | 3231238 | 1.92% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $12701945 | 3017089 | 1.79% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $10622431 | 2522891 | 1.50% | शेयर |
| TWO SIGMA ADVISERS, LP | $10582137 | 3140100 | 1.49% | शेयर |
| MACKENZIE FINANCIAL CORP | $9967146 | 2367493 | 1.41% | शेयर |
| MORGAN STANLEY | $7830240 | 1859914 | 1.10% | शेयर |
| Connor, Clark & Lunn Investment Management Ltd. | $7627316 | 1811714 | 1.08% | शेयर |
| NORTHERN TRUST CORP | $5784430 | 1373974 | 0.82% | शेयर |
| Hillsdale Investment Management Inc. | $5264302 | 1250428 | 0.74% | शेयर |
| WELLS FARGO & COMPANY/MN | $5078094 | 1206198 | 0.72% | शेयर |
| DEUTSCHE BANK AG\ | $4875761 | 1158138 | 0.69% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $4379810 | 1040335 | 0.62% | शेयर |
| FRANKLIN RESOURCES INC | $4239382 | 1006979 | 0.60% | शेयर |
| FMR LLC | $3828942 | 909488 | 0.54% | शेयर |
| STATE OF WISCONSIN INVESTMENT BOARD | $3277548 | 778515 | 0.46% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $3052608 | 725085 | 0.43% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $2772104 | 658457 | 0.39% | शेयर |
| IEQ CAPITAL, LLC | $2364286 | 561588 | 0.33% | शेयर |
| Vanguard Global Advisers, LLC | $2361970 | 561038 | 0.33% | शेयर |
| PRUDENTIAL FINANCIAL INC | $2261608 | 537199 | 0.32% | शेयर |
| Bank of New York Mellon Corp | $2142384 | 508880 | 0.30% | शेयर |
| CITADEL ADVISORS LLC | $2115117 | 502403 | 0.30% | शेयर |
| VOYA INVESTMENT MANAGEMENT LLC | $2039535 | 484450 | 0.29% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $1973737 | 468821 | 0.28% | शेयर |
| SEI INVESTMENTS CO | $1934150 | 459417 | 0.27% | शेयर |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1897127 | 540492 | 0.27% | शेयर |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1847815 | 438911 | 0.26% | शेयर |
| Inspire Investing, LLC | $1789893 | 509941 | 0.25% | शेयर |
| SEGALL BRYANT & HAMILL, LLC | $1717949 | 408064 | 0.24% | शेयर |
| Invesco Ltd. | $1697510 | 403209 | 0.24% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1670528 | 396800 | 0.24% | पुट ऑप्शन |
| Man Group plc | $1650813 | 392117 | 0.23% | शेयर |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1641029 | 389793 | 0.23% | शेयर |
| UBS Group AG | $1639917 | 389529 | 0.23% | शेयर |
कार्यकर्ता और 5%+ मालिक 4 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Sarissa Capital Management LP, Alexander J. Denner | 19 मार्च 2026 | 5.80% | संशोधन | · | SEC |
| Ironwood Pharmaceuticals, Inc. | 7 जुलाई 2023 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| OR ×3 फाइलिंग | 1 मार्च 2021 | · | प्रारंभिक फाइलिंग | · | SEC |
| 9 नवमबर 2020 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 41 इनसाइडर्स · 18 अधिकारी · 22 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Thomas A Mccourt | Chief Executive Officer | 10 मार्च 2026 A | 1898838 | 0 | 2 | $-739929 |
| Mark Mallon | Chief Executive Officer | 26 फ़रवरी 2021 S | 470605 | 0 | 0 | $0 |
| Peter M. Hecht | Chief Executive Officer | 1 अप्रैल 2019 D | 2217366 | 0 | 0 | $0 |
| Gregory S. Martini | Chief Financial Officer | 10 मार्च 2026 A | 297213 | 0 | 2 | $-81888 |
| Sravan Kumar Emany | SVP, COO and CFO | 18 नवमबर 2024 S | 309572 | 0 | 0 | $0 |
| Gina Consylman | SVP, CFO & Treasurer | 26 मार्च 2021 A | 392616 | 0 | 0 | $0 |
| Jason Rickard | SVP, Chief Operating Officer | 8 मार्च 2023 A | 376316 | 0 | 0 | $0 |
| William Huyett | Chief Operating Officer | 1 अप्रैल 2019 D | 27546 | 0 | 0 | $0 |
| Michael J Higgins | Chief Operating Officer | 23 दिसमबर 2014 M | 329102 | 0 | 0 | $0 |
| Jeffrey Silber | SVP, CMO, Head-Res&Drug | 20 जुलाई 2026 A | 137036 | 0 | 0 | $0 |
| Ronald Silver | PFO & PAO | 7 जुलाई 2026 S | 313680 | 0 | 4 | $-831183 |
| Tammi L Gaskins | Chief Commercial Officer | 10 मार्च 2026 A | 350350 | 0 | 3 | $-100301 |
| Minardo John | Chief Legal Officer | 10 मार्च 2026 A | 500498 | 0 | 2 | $-136177 |
| Michael Shetzline | SVP, CMO, Head-Res&Drug | 10 मार्च 2026 A | 658037 | 0 | 2 | $-121586 |
| Andrew Davis | SVP, Chief Business Officer | 18 नवमबर 2024 S | 284685 | 0 | 0 | $0 |
| Conor Kilroy | SVP, GC & Secretary | 26 फ़रवरी 2021 S | 122336 | 0 | 0 | $0 |
| Kelly Macdonald | Chief Accounting Officer | 4 दिसमबर 2020 M | 93041 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Admin Officer & SVP | 21 फ़रवरी 2020 S | 265991 | 0 | 0 | $0 |
| DENNER ALEXANDER J | निदेशक | 15 सितमबर 2026 A | 327549 | 0 | 2 | $-20530448 |
| Catherine Moukheibir | निदेशक | 16 जून 2026 A | 181425 | 0 | 0 | $0 |
| Jon R Duane | निदेशक | 16 जून 2026 A | 253820 | 0 | 0 | $0 |
| Marla L Kessler | निदेशक | 16 जून 2026 A | 229364 | 0 | 0 | $0 |
| Jay Shepard | निदेशक | 16 जून 2026 A | 235036 | 0 | 0 | $0 |
| Julie Mchugh | निदेशक | 16 जून 2026 S | 250749 | 0 | 1 | $-80460 |
| Mark G Currie | निदेशक | 16 जून 2026 A | 676900 | 0 | 0 | $0 |
| Andrew Dreyfus | निदेशक | 10 जून 2025 A | 228313 | 0 | 0 | $0 |
| Edward P Owens | निदेशक | 2 जून 2021 A | 241720 | 0 | 0 | $0 |
| Lawrence S Olanoff | निदेशक | 2 जून 2021 A | 91395 | 0 | 0 | $0 |
| Amy Schulman | निदेशक | 1 अप्रैल 2019 D | 38242 | 0 | 0 | $0 |
| Marsha Fanucci | निदेशक | 1 अप्रैल 2019 D | 132663 | 0 | 0 | $0 |
| Douglas E Williams | निदेशक | 1 अप्रैल 2019 D | 87800 | 0 | 0 | $0 |
| Terrance McGuire | निदेशक | 1 अप्रैल 2019 D | 73630 | 0 | 0 | $0 |
| WALSH CHRISTOPHER T PHD | निदेशक | 15 मार्च 2017 A | 71499 | 0 | 0 | $0 |
| George N Conrades | निदेशक | 3 जून 2015 A | 62221 | 0 | 0 | $0 |
| David A Ebersman | निदेशक | 13 मार्च 2015 A | 29714 | 0 | 0 | $0 |
| COOK JOSEPH C JR | निदेशक | 12 मार्च 2015 S | 304080 | 0 | 0 | $0 |
| David Evans Shaw | निदेशक | 14 मार्च 2014 A | 64306 | 0 | 0 | $0 |
| VR Management LLC | 10% मालिक | 15 जनवरी 2013 J | 2442 | 0 | 0 | $0 |
| FMR LLC | 10% मालिक | 10 जुलाई 2012 S | 2340891 | 0 | 0 | $0 |
| Thomas Graney | · | 27 फ़रवरी 2017 A | 42013 | 0 | 0 | $0 |
| Bryan E Roberts | · | 15 जून 2015 A | 31951 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 33 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.60% | 371823 NS | 31 जुलाई 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.46% | 28214 SH | 2 अक्टूबर 2026 | दैनिक |
| LABU · Direxion Shares ETF Trust | 0.16% | 186886 NS | 31 जुलाई 2026 | N-PORT |
| IWC · iShares Trust | 0.15% | 554146 SH | 11 सितमबर 2026 | दैनिक |
| VFVA · VANGUARD WELLINGTON FUND | 0.13% | 267285 SH | 19 अगस्त 2026 | दैनिक |
| CALF · Pacer Funds Trust | 0.12% | 1079411 NS | 31 जुलाई 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.11% | 521040 SH | 19 अगस्त 2026 | दैनिक |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.10% | 135991 NS | 31 जुलाई 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.08% | 466785 NS | 31 जुलाई 2026 | N-PORT |
| IBB · iShares Trust | 0.05% | 1214535 SH | 11 सितमबर 2026 | दैनिक |
| PWS · Pacer Funds Trust | 0.04% | 2553 NS | 31 जुलाई 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.04% | 11684 SH | 2 अक्टूबर 2026 | दैनिक |
| IWO · iShares Trust | 0.04% | 1446914 SH | 11 सितमबर 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.04% | 165563 SH | 19 अगस्त 2026 | दैनिक |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.04% | 281417 SH | 2 अक्टूबर 2026 | दैनिक |
| RSSL · Global X Funds | 0.02% | 78252 NS | 31 जुलाई 2026 | N-PORT |
| IWM · iShares Trust | 0.02% | 4241422 SH | 11 सितमबर 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 943404 SH | 19 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.01% | 534999 NS | 31 जुलाई 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1677357 SH | 19 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.01% | 437643 SH | 19 अगस्त 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.00% | 272518 NS | 31 जुलाई 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 8700 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 11833 NS | 31 जुलाई 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 197587 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.00% | 41467 SH | 9 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.00% | 32200 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 11941 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4781484 SH | 19 अगस्त 2026 | दैनिक |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9494 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 13354 SH | 19 अगस्त 2026 | दैनिक |
| IWN · iShares Trust | · | 92403 SH | 11 सितमबर 2026 | दैनिक |
| SMLF · iShares Trust | · | 383496 SH | 11 सितमबर 2026 | दैनिक |
IRWD विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 10 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$5.35
+47.0%
2 20.0%
मजबूत खरीद
5 50.0%
खरीदें
3 30.0%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
4 विश्लेषक · 2026-09-30माध्य लक्ष्य $6.10 +67.6%
← सभी लक्ष्यों से नीचे
वर्तमान मूल्य $3.64
निम्न$3.70
माध्य$6.10
उच्च$10.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 6, 2026 को फाइल किया गया